Inactive Instrument
Quest PharmaTech Inc. Share Price Other OTC
Stocks
QPTFF
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 33.83L 24.12L 20.9L 19.49L 17.93L 23Cr 34.22L 2.29Cr 89.69L 12Cr 90.67L 88.68L 38Cr | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 43.68L 31.15L 26.99L 25.16L 23.16L 30Cr 44.19L 2.96Cr 1.16Cr 15Cr 1.17Cr 1.15Cr 49Cr | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -34.61% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 17/06/2004 | |
J. Lievonen
CHM | Chairman | - | 05/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -34.61% | +0.12% | - | - | 24.05L | |
| +0.90% | +0.21% | -0.74% | +13.87% | 4.8TCr | |
| +1.98% | +7.31% | +430.66% | +532.17% | 4.11TCr | |
| +3.44% | -2.84% | +29.17% | +8.81% | 3.76TCr | |
| +1.40% | -0.89% | +7.63% | +61.93% | 3.59TCr | |
| +2.42% | +7.27% | +14.90% | +44.79% | 2.99TCr | |
| -0.16% | -4.02% | - | - | 1.61TCr | |
| +2.20% | +2.94% | +35.92% | +127.15% | 1.61TCr | |
| +1.25% | +1.69% | +4.72% | +18.26% | 1.38TCr | |
| +4.25% | -9.28% | -0.78% | -35.46% | 1.21TCr | |
| Average | -1.69% | -2.15% | +65.18% | +96.44% | 2.78TCr | |
| Weighted average by Cap. | +1.91% | -1.29% | +85.86% | +120.78% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -18.01L -12.85L -11.13L -10.37L -10L -12Cr -18.22L -1.22Cr -47.75L -6.13Cr -48.28L -47.22L -20Cr | 49.98L 35.65L 30.88L 28.79L 26.5L 34Cr 50.56L 3.38Cr 1.33Cr 17Cr 1.34Cr 1.31Cr 56Cr |
| Net Debt | 8L 6L 5L 5L 4L 5.39Cr 8L 53.78L 21.08L 2.7Cr 21.31L 20.84L 8.95Cr | 10L 7L 6L 6L 5L 6.69Cr 10L 66.68L 26.13L 3.35Cr 26.42L 25.84L 11Cr |
Employees
-
